封面
市场调查报告书
商品编码
2018816

护理设备市场:按类型、产品类别、分销管道和最终用户划分-2026-2032年全球市场预测

Long Term Care Devices Market by Type, Product Type, Distribution Channel, End Users - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年老年护理设备市场价值为2,397.1亿美元,预计2026年将成长至2,564.7亿美元,年复合成长率为7.55%,到2032年将达到3992.4亿美元。

主要市场统计数据
基准年 2025 2397.1亿美元
预计年份:2026年 2564.7亿美元
预测年份 2032 3992.4亿美元
复合年增长率 (%) 7.55%

从策略角度展望医疗设备创新、护理服务转型和采购趋势如何重新定义长期照护结果和营运重点。

长期照护医疗设备产业处于临床需求、人口压力和快速技术创新三者交汇的阶段,这要求医疗服务提供者、製造商和支付方制定清晰的策略方向。本执行摘要首先指出,持续的病患疗效和永续的照护服务在很大程度上取决于医疗设备在机构和家庭环境中的部署方式,以及产品设计和互通性。接下来的分析整合了市场动态、监管影响、分销趋势和新兴技术部署模式,旨在为领导者提供实际的决策基础。

临床监测、数位整合、行动优先设计和基于结果的采购如何从根本上改变长期照护的提供和医疗设备。

长期照护领域正经历着变革性的转变,这主要得益于临床实务、技术和人口健康管理趋势的融合。其中一个主要趋势是转向持续远端监测,模糊了急性照护监测和常规长期照护之间的界限,从而能够早期疗育并改善慢性病管理。同时,数位平台和分析技术正在增强医疗设备的功能,更聪明的数据整合使临床医生和护理协调员能够更有效地选择资源,并提供针对个人风险状况量身定制的干预措施。

本研究评估了美国最近的关税措施如何促使长期照护设备的製造商和买家重组其供应链、重新设计产品并柔软性。

美国近期关税趋势为长期照护设备产业的供应链规划和产品采购决策带来了新的复杂性。影响零件、成品或包装的关税会造成多层次的成本压力,并波及製造和分销合同,促使企业重新评估供应商选择以及近岸和在岸製造方案。除了直接的成本影响外,关税波动也促使企业透过多元化采购、库存缓衝策略和关键零件的策略性储备来增强供应链的韧性。

详细的細項分析揭示了设备类型、外形规格、通路和多样化的护理环境如何影响部署、采购和服务策略。

细分市场分析揭示了不同设备类别、产品形式、通路和终端用户环境下的部署、商业化和服务差异化路径。按类型划分,市场可分为诊断、行动辅助和治疗三大类。诊断产品包括床边警报器、血压计、心电图 (ECG) 和心电图监测、跌倒侦测系统、血糖值仪、脉动式血氧监测仪系统、智慧型药盒、智慧穿戴监测设备和体温计,每种产品都针对不同的监测频率和临床需求。行动辅助设备包括拐杖和手杖、居家医疗家具、助行器和轮椅,所有这些产品都旨在维持身体功能、降低跌倒风险并减轻看护者的负担。治疗设备包括沟通辅助设备、家用透析机、家用输液帮浦、家用呼吸照护设备、胰岛素给药系统以及创伤护理和疼痛管理设备,这些设备既可用于慢性病治疗,也可用于居家急性介入。

将美洲、欧洲、中东和非洲以及亚太地区的区域趋势进行比较,这些趋势影响产品采用和打入市场策略,以及它们的战略意义。

区域趋势正在影响监管方式、报销途径、供应链韧性和临床偏好,从而在全球市场造成不同的策略挑战。在美洲,政策重点关注「居家养老」和家庭慢性病管理,这推动了对整合监测解决方案和支援独立生活的行动辅助设备的需求。北美保险公司和医疗服务提供者也更乐于接受能够降低住院率和显着降低成本的证据,从而促进了设备製造商和医疗网路之间的合作。

领先的製造商和服务供应商如何透过整合解决方案、互通性和价值主导的服务模式来实现差异化并满足长期照护需求。

在长期照护设备领域,竞争优势越来越依赖整合能力、服务模式以及能够证明临床和经济效益的证据。主要企业不再仅仅销售产品,而是提供捆绑式解决方案,将设备、用于资料聚合的软体平台以及支援安装、培训和长期维护的管理服务相结合。这种垂直整合模式减轻了采购机构的负担,为供应商提供了持续的收入来源,并提高了临床团队的资料连续性。

领导者应采取切实可行的策略方法和营运重点,以优化产品设计、供应链韧性、互通性和以结果主导的商业化。

产业领导者应优先采取一系列切实可行的措施,使产品开发、商业模式和营运韧性与不断变化的长期照护生态系统需求保持一致。首先,投资于产品模组化和看护者为中心的设计,以提高产品在辅助住宅、居家照护、临终关怀、养老院、医院和復健机构等环境中的易用性。其次,透过供应商多元化、探索区域製造伙伴关係关係以及减少对关税敏感组件依赖的产品设计,增强价值链韧性。第三,制定以结果为导向的价值提案,将设备性能与可衡量的临床终点和运营效率联繫起来,从而在与支付方和医疗服务提供方的合约谈判中占据更有利的地位。

概述了用于得出长期照护设备策略实用见解的调查方法,包括严格的一级和二级调查、相关人员检验和证据加权分析。

本分析结合了对临床采购经理、医疗设备製造商和护理人员的访谈,以及对监管政策更新、供应链资讯披露和供应商技术规范等第二手资料的审查。此外,还与不同长期照护机构的临床医生进行了深入讨论,检验推动医疗器材普及和营运限制的因素,从而为定性资讯提供支援。这种方法强调从最终用户、相关人员和技术专家的观点进行三角验证,以确保提出的建议能够反映实际应用情况,而非仅仅是理论构想。

最终的综合分析强调了创新、互通性和供应链策略对于不断发展的长期照护设备生态系统的成功至关重要。

总之,长期照护设备产业正处于转折点,临床需求、人口压力和技术融合为能够快速、精准地适应市场变化的供应商和製造商创造了明确的机会。优先考虑持续监测、行动辅助和治疗自主性的设备将在实现更安全的居家照护和更有效率的院内工作流程方面发挥核心作用。同时,商业性成功将取决于供应链的韧性、基于实证的价值提案以及与护理服务体系的无缝整合。

目录

第一章:序言

第二章:调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵,2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章:美国关税的累积影响,2025年

第七章:人工智慧的累积影响,2025年

第八章:护理设备市场:按类型划分

  • 诊断
    • 床边警报
    • 血压监测仪
    • 心电图和心电图监测
    • 跌倒侦测系统
    • 血糖值监测仪
    • 脉动式血氧监测仪系统
    • 智慧药物管理设备
    • 用于监测的智慧穿戴设备
    • 体温计
  • 行动支持
    • 拐杖/手杖
    • 居家医疗家具
    • 助行器和轮滑鞋
    • 轮椅
  • 治疗
    • 通讯支援设备
    • 家用透析设备
    • 家用静脉输液泵
    • 家用呼吸照护设备
    • 胰岛素给药
    • 创伤护理和疼痛管理设备

第九章:护理设备市场:依产品类型划分

  • 非穿戴式装置
  • 穿戴式装置

第十章:护理设备市场:依通路划分

  • 离线
  • 在线的

第十一章:护理设备市场:依最终使用者划分

  • 辅助住宅
  • 居家照护环境
  • 临终关怀和护理机构
  • 医院
  • 復健中心

第十二章:护理设备市场:按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章:护理设备市场:依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章:护理设备市场:依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章:美国医疗设备市场

第十六章:中国养老设备市场

第十七章 竞争格局

  • 市场集中度分析,2025年
    • 浓度比(CR)
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析,2025 年
  • 2025年产品系列分析
  • 基准分析,2025 年
  • Abbott Laboratories
  • ARKRAY Inc.
  • Asahi Kasei Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • BMC Medical Co., Ltd.
  • Boston Scientic Corporation
  • Cardinal Health, Inc.
  • Compass Health Brands
  • Drive DeVilbiss Healthcare
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG
  • GE HealthCare
  • Getinge AB
  • GF Health Products, Inc.
  • Honeywell International Inc.
  • Invacare Holdings Corporation
  • Johnson & Johnson Services Inc.
  • Koninklijke Philips NV
  • Linde PLC
  • Medline Industries, LP
  • Medtronic PLC
  • Omron Corporation
  • PHC Holdings Corporation
  • ResMed Inc.
  • Siemens Healthineers AG
  • Solventum
  • Sunrise Medical LLC
  • Vayyar Care
Product Code: MRR-ED54C46E883C

The Long Term Care Devices Market was valued at USD 239.71 billion in 2025 and is projected to grow to USD 256.47 billion in 2026, with a CAGR of 7.55%, reaching USD 399.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 239.71 billion
Estimated Year [2026] USD 256.47 billion
Forecast Year [2032] USD 399.24 billion
CAGR (%) 7.55%

A strategic orientation to how device innovation, care delivery transformation, and procurement dynamics are redefining long-term care outcomes and operational priorities

The long-term care devices sector sits at the intersection of clinical necessity, demographic pressure, and rapid technological innovation, demanding a clear strategic orientation from providers, manufacturers, and payers. This executive summary opens with the premise that durable patient outcomes and sustainable care delivery depend as much on product design and interoperability as on how devices are deployed across institutional and home-based settings. The following analysis synthesizes market dynamics, regulatory influences, distribution behavior, and emergent technology adoption patterns to offer leaders a pragmatic foundation for decisions.

Early paragraphs in this report focus on the forces reshaping procurement cycles and clinical pathways, highlighting the shift from episodic to continuous care, the prioritization of remote monitoring, and the drive toward devices that reduce caregiver burden while improving patient autonomy. Readers will find context on the types of devices that are gaining adoption in long-term care environments, the structural changes in distribution and purchasing, and the competitive behaviors that are redefining value propositions. The goal is to equip senior executives with a clear lens to identify strategic priorities, operational risks, and immediate opportunities for targeted investment or partnership.

How clinical monitoring, digital integration, mobility-first design, and outcome-based procurement are fundamentally transforming long-term care delivery and device adoption

The long-term care landscape is undergoing transformative shifts driven by converging trends in clinical practice, technology, and population health management. A primary movement is toward continuous remote monitoring that blurs the lines between acute care oversight and routine long-term support, enabling earlier intervention and better management of chronic conditions. Simultaneously, digital platforms and analytics are augmenting device function; smarter data integration is allowing clinicians and care coordinators to triage resources more effectively and tailor interventions to individual risk profiles.

Another defining shift is the elevation of mobility and independence as central design criteria. Devices that address mobility assistance alongside diagnostics and therapeutics are being adopted to reduce institutionalization and extend safe home-based care. This has important implications for product development, as manufacturers increasingly prioritize modularity, ease of use, and caregiver-friendly features. Regulatory pathways and reimbursement frameworks are also evolving to recognize the value of remote and home-based interventions, which in turn accelerates strategic partnerships between device makers, service providers, and technology platforms. Finally, procurement behaviors are shifting toward outcome-based purchasing and bundled-care arrangements, which favors vendors that can demonstrate longitudinal impact, interoperability, and efficient service models.

Evaluating how recent United States tariff measures are prompting supply chain realignment, product redesign, and procurement flexibility across long-term care device manufacturers and buyers

Recent tariff activity in the United States has introduced tangible complexity into supply chain planning and product sourcing decisions for the long-term care devices sector. Tariffs that affect components, finished devices, or packaging create layered cost pressures that cascade through manufacturing contracts and distribution agreements, prompting companies to reassess supplier footprints and nearshore versus onshore manufacturing options. In addition to direct cost implications, tariff-driven volatility incentivizes firms to strengthen supply chain resilience through multi-sourcing, inventory buffering strategies, and strategic stockpiling of critical components.

Beyond operational shifts, tariff dynamics influence product roadmaps and pricing strategies. Manufacturers are responding by redesigning products to reduce exposure to high-tariff inputs, negotiating long-term supplier commitments, and exploring alternative materials that maintain performance while lowering tariff risk. For purchasers in care settings, these changes can lengthen lead times and complicate procurement forecasting, prompting a need for more flexible contracting and clearer communication between suppliers and buyers. In the aggregate, tariffs are a catalyst for supply chain realignment and strategic cost management, with companies that proactively adapt gaining competitive advantage in stability and margin preservation.

In-depth segmentation insights that clarify how device type, form factor, distribution pathway, and diverse care environments shape adoption, procurement, and service strategies

Segmentation analysis reveals distinct pathways for adoption, commercialization, and service differentiation across device categories, product forms, channels, and end-user settings. When considered by Type, the market splits into Diagnostic, Mobility Assist, and Therapeutic categories. Diagnostic offerings include bed alarms, blood pressure monitors, ECG and Holter monitors, fall detection systems, glucose monitors, pulse oximeters, smart pill dispensers, smart wearables for monitoring, and thermometers, each serving different monitoring cadences and clinical priorities. Mobility Assist devices encompass crutches and canes, home medical furniture, walkers and rollators, and wheelchairs, all of which target physical function, fall risk mitigation, and caregiver workload reduction. Therapeutic devices cover assistive communication devices, home dialysis equipment, home IV pumps, home respiratory care devices, insulin delivery systems, and wound care and pain management devices, addressing both chronic therapy delivery and acute at-home interventions.

When viewed by Product Type, distinctions between non-wearable devices and wearable devices become critical for placement, reimbursement, and user adherence. Non-wearable devices often anchor facility-based workflows or home-furnishing solutions, whereas wearable devices enable continuous monitoring and can shift care from institutional settings to decentralized models. Distribution Channel is another defining axis; offline channels remain essential for high-touch procurement, training, and installation, while online channels accelerate adoption for lower-complexity items and enable rapid replenishment. Finally, End Users such as assisted living facilities, home care settings, hospices and nursing homes, hospitals, and rehabilitation centers each have unique purchasing protocols, clinical staffing profiles, and spatial constraints that determine device suitability. Strategic segmentation that accounts for device type, form factor, channel, and end-user context is essential for go-to-market decisions, pricing strategies, and post-sale service models.

Comparative regional dynamics and strategic implications across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence product adoption and market entry strategies

Regional dynamics influence regulatory approaches, reimbursement pathways, supply chain resilience, and clinical preferences, producing distinct strategic imperative across global markets. In the Americas, policy focus on aging-in-place and home-based chronic disease management is driving demand for integrated monitoring solutions and mobility aids that support independence. North American payers and providers are also more receptive to evidence demonstrating reduced hospitalizations and measurable cost offsets, encouraging partnerships between device manufacturers and care networks.

The Europe, Middle East & Africa region presents a mosaic of regulatory regimes and reimbursement models, increasing the importance of localized clinical evidence and regional market entry strategies. Western European markets emphasize device safety, interoperability, and data protection, while emerging markets within the region exhibit variability in procurement sophistication and care delivery models. The Asia-Pacific region is characterized by rapid adoption of mobile-enabled health technologies and an escalating focus on home care infrastructure to serve large aging populations. Manufacturers entering Asia-Pacific must balance the pace of digital adoption with diverse local regulatory requirements and supply chain considerations. Across all regions, strategic advantages accrue to organizations that can adapt product offerings, support models, and pricing to local regulatory landscapes and care delivery norms.

How leading manufacturers and service providers are differentiating through integrated solutions, interoperability, and value-driven service models to capture long-term care demand

Competitive positioning in the long-term care devices sector increasingly depends on integration capabilities, service models, and evidence demonstrating clinical and economic impact. Leading companies are moving beyond product sales to deliver bundled solutions that combine devices, software platforms for data aggregation, and managed services to support installation, training, and long-term maintenance. Such vertically integrated models reduce friction for procuring organizations and create recurring revenue streams for vendors, while also improving data continuity for clinical teams.

Innovation leadership is also shifting toward collaborations between device manufacturers and digital health firms that can provide analytics, predictive risk modeling, and secure data exchange. Companies that invest in interoperability standards and clinician-centered design are winning pilot programs and scalable deployments. At the same time, supplier differentiation is emerging through specialized service offerings such as rapid deployment teams for institutional rollouts, warranty and lifecycle management that extend device usefulness, and clinician training programs that increase adherence and reduce misuse. Strategic acquisitions and partnerships are accelerating capability build-outs among firms seeking to offer end-to-end solutions for long-term care providers.

Practical strategic initiatives and operational priorities leaders must adopt to optimize product design, supply chain resilience, interoperability, and outcome-driven commercialization

Industry leaders should prioritize a set of actionable moves that align product development, commercial models, and operational resilience with the evolving needs of long-term care ecosystems. First, invest in product modularity and caregiver-centric design to enhance usability across assisted living, home care, hospice, nursing, hospital, and rehabilitation environments. Second, strengthen supply chain resilience by diversifying suppliers, considering regional manufacturing partnerships, and designing products that reduce reliance on tariff-sensitive components. Third, develop outcome-oriented value propositions that tie device performance to measurable clinical endpoints and operational efficiencies, enabling stronger contracting positions with payers and providers.

In addition, companies should accelerate interoperability efforts and open-data partnerships to ensure that devices integrate seamlessly with electronic health records and care coordination platforms, thereby enhancing clinical workflows. Sales and marketing teams must craft differentiated channel strategies that recognize the ongoing importance of offline relationships for complex device installations while expanding online capabilities for rapid replenishment and lower-complexity product distribution. Finally, prepare for regulatory and reimbursement shifts by building evidence through pragmatic clinical studies and real-world data collection that demonstrate both clinical benefit and cost-effectiveness. These initiatives will position organizations to capture growth opportunities while mitigating operational and commercial risks.

Methodology overview describing rigorous primary and secondary research, stakeholder triangulation, and evidence-weighted analysis used to derive actionable insights for long-term care device strategies

This analysis synthesizes primary interviews with clinical procurement leaders, device manufacturers, and care operators, combined with secondary review of regulatory policy updates, supply chain disclosures, and vendor technical specifications. Qualitative inputs were corroborated through targeted discussions with clinicians across long-term care settings to validate adoption drivers and operational constraints. The approach places emphasis on triangulating perspectives from end users, procurement stakeholders, and technical experts to ensure recommendations reflect pragmatic implementation realities rather than theoretical constructs.

Data interpretation prioritized thematic consistency across sources and sought to surface actionable insights rather than presentographic summaries. Where divergent viewpoints emerged, the methodology applied a weighted assessment to reconcile differences based on the credibility of the source, the scale of the operation described, and the relevance to long-term care contexts. This iterative process ensures that conclusions are grounded in observable trends, practitioner experience, and documented policy shifts, yielding guidance that supports decision-making for manufacturers, providers, and strategic investors.

Final synthesis highlighting how innovation, interoperability, and supply chain strategy will determine success in the evolving long-term care devices ecosystem

In conclusion, the long-term care devices sector is at an inflection point where clinical need, demographic pressure, and technology convergence present clear opportunities for providers and manufacturers that can adapt quickly and thoughtfully. Devices that prioritize continuous monitoring, mobility support, and therapeutic autonomy will be central to enabling safer home-based care and more efficient institutional workflows. At the same time, commercial success will hinge on supply chain resilience, evidence-based value propositions, and seamless integration with care delivery systems.

Leaders who adopt modular product designs, invest in interoperability, and cultivate flexible distribution channels will be best positioned to translate innovation into adoption. Strategic focus on outcome alignment, regulatory preparedness, and responsive customer service will differentiate vendors in an increasingly outcome-conscious procurement environment. The insights in this summary are intended to support immediate strategic planning and to inform longer-term investments that align with the sector's trajectory toward decentralized, data-enabled, and patient-centered care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Long Term Care Devices Market, by Type

  • 8.1. Diagnostic
    • 8.1.1. Bed Alarms
    • 8.1.2. Blood Pressure Monitors
    • 8.1.3. ECG & Holter Monitors
    • 8.1.4. Fall Detection Systems
    • 8.1.5. Glucose Monitors
    • 8.1.6. Pulse Oximeters
    • 8.1.7. Smart Pill Dispensers
    • 8.1.8. Smart Wearables for Monitoring
    • 8.1.9. Thermometers
  • 8.2. Mobility Assist
    • 8.2.1. Crutches & Canes
    • 8.2.2. Home Medical Furniture
    • 8.2.3. Walkers & Rollators
    • 8.2.4. Wheelchair
  • 8.3. Therapeutic
    • 8.3.1. Assistive Communication Devices
    • 8.3.2. Home Dialysis Equipment
    • 8.3.3. Home IV Pumps
    • 8.3.4. Home Respiratory Care Devices
    • 8.3.5. Insulin Delivery
    • 8.3.6. Wound Care & Pain Management Devices

9. Long Term Care Devices Market, by Product Type

  • 9.1. Non-Wearable Devices
  • 9.2. Wearable Devices

10. Long Term Care Devices Market, by Distribution Channel

  • 10.1. Offline
  • 10.2. Online

11. Long Term Care Devices Market, by End Users

  • 11.1. Assisted Living Facilities
  • 11.2. Home Care Settings
  • 11.3. Hospices & Nursing Homes
  • 11.4. Hospitals
  • 11.5. Rehabilitation Centers

12. Long Term Care Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Long Term Care Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Long Term Care Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Long Term Care Devices Market

16. China Long Term Care Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. ARKRAY Inc.
  • 17.7. Asahi Kasei Corporation
  • 17.8. B. Braun SE
  • 17.9. Baxter International Inc.
  • 17.10. Becton, Dickinson and Company
  • 17.11. BMC Medical Co., Ltd.
  • 17.12. Boston Scientic Corporation
  • 17.13. Cardinal Health, Inc.
  • 17.14. Compass Health Brands
  • 17.15. Drive DeVilbiss Healthcare
  • 17.16. F. Hoffmann-La Roche Ltd.
  • 17.17. Fresenius Medical Care AG
  • 17.18. GE HealthCare
  • 17.19. Getinge AB
  • 17.20. GF Health Products, Inc.
  • 17.21. Honeywell International Inc.
  • 17.22. Invacare Holdings Corporation
  • 17.23. Johnson & Johnson Services Inc.
  • 17.24. Koninklijke Philips N.V.
  • 17.25. Linde PLC
  • 17.26. Medline Industries, LP
  • 17.27. Medtronic PLC
  • 17.28. Omron Corporation
  • 17.29. PHC Holdings Corporation
  • 17.30. ResMed Inc.
  • 17.31. Siemens Healthineers AG
  • 17.32. Solventum
  • 17.33. Sunrise Medical LLC
  • 17.34. Vayyar Care

LIST OF FIGURES

  • FIGURE 1. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LONG TERM CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LONG TERM CARE DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES LONG TERM CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA LONG TERM CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY BED ALARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY BED ALARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY BED ALARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY ECG & HOLTER MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY ECG & HOLTER MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY ECG & HOLTER MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY FALL DETECTION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY FALL DETECTION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY FALL DETECTION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY PULSE OXIMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY PULSE OXIMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY PULSE OXIMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY SMART PILL DISPENSERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY SMART PILL DISPENSERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY SMART PILL DISPENSERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY SMART WEARABLES FOR MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY SMART WEARABLES FOR MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY SMART WEARABLES FOR MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY THERMOMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY THERMOMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY THERMOMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY CRUTCHES & CANES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY CRUTCHES & CANES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY CRUTCHES & CANES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME MEDICAL FURNITURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME MEDICAL FURNITURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME MEDICAL FURNITURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY WALKERS & ROLLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY WALKERS & ROLLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY WALKERS & ROLLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY WHEELCHAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY WHEELCHAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY WHEELCHAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY ASSISTIVE COMMUNICATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY ASSISTIVE COMMUNICATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY ASSISTIVE COMMUNICATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME DIALYSIS EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME DIALYSIS EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME DIALYSIS EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME IV PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME IV PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME IV PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME RESPIRATORY CARE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME RESPIRATORY CARE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME RESPIRATORY CARE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY WOUND CARE & PAIN MANAGEMENT DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY WOUND CARE & PAIN MANAGEMENT DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY WOUND CARE & PAIN MANAGEMENT DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY NON-WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY NON-WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY NON-WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOSPICES & NURSING HOMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOSPICES & NURSING HOMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOSPICES & NURSING HOMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS LONG TERM CARE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE LONG TERM CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST LONG TERM CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC LONG TERM CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN LONG TERM CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 176. GCC LONG TERM CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GCC LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 179. GCC LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 180. GCC LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 181. GCC LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. GCC LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. GCC LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION LONG TERM CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS LONG TERM CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 200. G7 LONG TERM CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. G7 LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. G7 LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 203. G7 LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 204. G7 LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 205. G7 LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. G7 LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. G7 LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 208. NATO LONG TERM CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. NATO LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. NATO LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 211. NATO LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 212. NATO LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 213. NATO LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. NATO LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. NATO LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL LONG TERM CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES LONG TERM CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA LONG TERM CARE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA LONG TERM CARE DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA LONG TERM CARE DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA LONG TERM CARE DEVICES MARKET SIZE, BY MOBILITY ASSIST, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA LONG TERM CARE DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA LONG TERM CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA LONG TERM CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA LONG TERM CARE DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)